WCM
RMD icon

Winton Capital Management’s ResMed RMD Stock Holding History

Winton Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$29.1M Buy
650,724
+309,890
+91% +$13.9M 0.2% 206
2013
Q4 		$16M Buy
340,834
+102,566
+43% +$5.19M 0.14% 257
2013
Q3 		$12.6M Buy
238,268
+192,572
+421% +$9.34M 0.15% 237
2013
Q2 		$2.06M Buy
+45,696
New +$2.17M 0.03% 381

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Winton Capital Management's RMD Position: Q1 2014 in Review

Winton Capital Management increased its ResMed (RMD) stake by 91% in Q1 2014, buying an estimated $13.9M and bringing the position to 650,724 shares worth $29.1M. The position accounts for 0.2% of the portfolio, ranked #206.

Winton Capital Management first reported a position in RMD in Q2 2013 and has held it in 4 quarters since. 319 funds tracked by Wall St. Rank hold RMD as of Q1 2014.

  • Winton Capital Management held 650,724 shares of ResMed worth $29.1M as of Q1 2014.
  • Winton Capital Management bought 309,890 ResMed shares in Q1 2014, an estimated $13.9M.
  • ResMed made up 0.2% of Winton Capital Management's portfolio in Q1 2014, its #206 holding.
  • Winton Capital Management first reported a position in ResMed in Q2 2013 and has held it in 4 quarters since.
  • 319 funds tracked by Wall St. Rank held ResMed as of Q1 2014.

Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.